(Q71236716)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

title

Treatment of scleromyxedema with 2-chlorodeoxyadenosine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

author name string

L S Davis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

S Sanal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

O P Sangueza

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

language of work or name

English

0 references

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

issue

2 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

288-290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Cladribine in treatment of chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Plasmapheresis in a patient with scleromyxedema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Successful treatment of scleromyxedema with plasmapheresis and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Scleromyxoedema--successful treatment with plasma exchange and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

Lichen Myxedematosus Serum Stimulates Human Skin Fibroblast Proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990650-7

7 January 2021

10.1016/S0190-9622(96)90650-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8698907%20AND%20SRC:MED&resulttype=core&format=json

17 October 2019

1 reference